Apexigen Statistics
Share Statistics
Apexigen has -
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 410 |
| FTD / Avg. Volume | 6.98% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.43 and the forward
PE ratio is null.
Apexigen's PEG ratio is
-0.01.
| PE Ratio | -0.43 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 2.12 |
| P/FCF Ratio | -0.44 |
| PEG Ratio | -0.01 |
Financial Ratio HistoryEnterprise Valuation
Apexigen has an Enterprise Value (EV) of -1.2M.
| EV / Sales | 0 |
| EV / EBITDA | 0.04 |
| EV / EBIT | 0.04 |
| EV / FCF | 0.04 |
Financial Position
The company has a current ratio of 1.29,
with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.29 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 52.98 |
Financial Efficiency
Return on Equity is -493.21% and Return on Invested Capital is -494.48%.
| Return on Equity | -493.21% |
| Return on Assets | -137.62% |
| Return on Invested Capital | -494.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -617K |
| Effective Tax Rate | 1.92% |
Stock Price Statistics
The stock price has increased by 14.81% in the
last 52 weeks. The beta is 0, so Apexigen's
price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | 14.81% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 52.55 |
| Average Volume (20 Days) | 5,877 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -32.69M |
| Net Income | -31.45M |
| EBITDA | -32.58M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.59 |
Full Income StatementBalance Sheet
The company has 14.8M in cash and 106K in
debt, giving a net cash position of 14.7M.
| Cash & Cash Equivalents | 14.8M |
| Total Debt | 106K |
| Net Cash | 14.7M |
| Retained Earnings | -176.79M |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -30.69M
and capital expenditures -57K, giving a free cash flow of -30.75M.
| Operating Cash Flow | -30.69M |
| Capital Expenditures | -57K |
| Free Cash Flow | -30.75M |
| FCF Per Share | -1.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
